Revenue Fresenius Medical Care on all time high (consensus analysts)

Tomorrow Fresenius Medical Care Medical Care will publish her past quarter's results. Based on the analyst expectation both the revenue and the net profit would be on all time high levels. For this year most of the analyst expect a total sales of 18,01 billion euros. The expectations of the revenue would mean a record revenue for the company. This is rather significant more than the 2015's revenue of 15,45 billion euros.

Historical revenues and results Fresenius Medical Care Medical Care plus taxations 2016

For 2016 the analysts foresee a record net profit of 1,24 billion euros. For this year most of the analysts expect a profit per share of 4,03 euros. Based on the analyst's expectations the price/earnings-ratio is 18,45.

The average of the dividends estimates is at 0,98 cents. The dividend yield consequently equals 1,32 percent. The average dividend yield of the health care company equals 0,66 percent.

Latest target prices around 92 euros

Fresenius Medical Care Medical Care is being covered by 19 analysts (only based on fundamental analysis). The average target price for the stock is at 88,68 euros. This is around 18 percent more than the current stock price of 74,35 euros. The 3 most recent recommendations for German were provided by HSBC (hold, 83,00 euros), Citigroup (buy, 98,00 euros) and Berenberg (buy, 94,00 euros).

Based on the number of outstanding shares Fresenius Medical Care Medical Care's market capitalization equals 22,7 billion euros.

The stock traded at 10.35 0,19 percent lower at 74,35 euros.

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.